Evidence map›Paper›PMID 30739270›Full record

ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2020

Development of a Plain Language Decision Support Tool for Cancer Clinical Trials: Blending Health Literacy, Academic Research, and Minority Patient Perspectives.

Aisha T Langford, Sarah T Hawley, Sue Stableford, Jamie L Studts, Margaret M Byrne

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Understanding Inclusion and Participation of People From Black African Diaspora Communities in Health and Care Research: A Realist Review.Health expectations : an international journal of public participation in health care and health policy · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Aisha T LangfordDepartment of Population Health, New York University School of Medicine, 227 East 30th Street, Room 645, New York, NY, 10016, USA. Aisha.Langford@nyumc.org.ORCID 0000-0003-1758-691X
Sarah T HawleyAnn Arbor VA Center of Excellence in Health Services Research & Development, University of Michigan Departments of Internal Medicine and Health Management & Policy, 2800 Plymouth Road, NCRC Building 16, 4th Floor, Ann Arbor, MI, 48109, USA.
Sue StablefordHealth Literacy, Plain Language, & Clear Health Communication Consultant, Brunswick, ME, USA.
Jamie L StudtsDepartment of Behavioral Science, University of Kentucky College of Medicine, 127 Medical Behavioral Science Building, Lexington, KY, 40536-0086, USA.
Margaret M ByrneDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, 4117 E Fowler St., Tampa, FL, 33612, USA.
Moffitt Cancer Center · USNew York University · USUniversity of Kentucky · USUniversity of Michigan · US

Funding

A Targeted Decision Aid to Improve Minority Participation in Clinical TrialsRC2MD004784 · NIMHD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BYRNE, MARGARET M · 2009 to 2010
$1.7M
NIMHD NIH HHS RC2 MD004784
6 · The paper itself

Abstract

Despite the promise of clinical trials for improving cancer care, less than 5% of all cancer patients participate. Racial/ethnic minorities continue to be underrepresented in cancer clinical trials (CCTs). To address this gap, we developed a plain language, web-based decision support tool (CHOICES DST) in English and Spanish to support decision-making about CCTs among Blacks and Hispanics. In phase 1 (information collection), we conducted qualitative interviews with 45 cancer patients, completed a thorough literature review, and reviewed results from a telephone survey of 1100 cancer patients. In phase 2 (content generation), we created the first iteration of the CHOICES DST. In phase 3 (usability testing), we gathered user experience and acceptability data from a small sample of cancer survivors (n = 9). The Knowledge, Empowerment, and Values Clarification (KEV) model of decision-making was developed based on data from phase 1. The KEV model and other phase 1 data allowed us to create the CHOICES DST platform. Usability testing of the CHOICES DST showed highly favorable responses from users, satisfaction with content, ease of navigation, and a desire to use the tool. Qualitative results identified addressable points that would benefit from content and navigation-related alterations. The final version of the CHOICES DST was well received and understood by Black and Hispanic participants, and adheres to the mandates for plain language communication. This research provides preliminary data that CHOICES DST holds promise for improving knowledge of CCTs and potentially improving informed decision-making about participation in trials.

Indexed as

CommunicationDecision MakingHealth LiteracyLanguagePatient Education as TopicBiomedical ResearchChoice BehaviorClinical Trials as TopicEthnicityHealth Knowledge, Attitudes, PracticeHumansMinority GroupsNeoplasmsPatient ParticipationAfrican AmericansCancer survivorsChoice behaviorClinical trials as topicComprehensionDecision makingHispanic AmericansInternetNeoplasmsPatient participation

Identifiers

PMID30739270
PMCPMC9575516
OpenAlexW2913512663

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.